|
Mr. LaBella brings over 20years experience to Cardiokine. He joined in September 2004 and has held various executive positions in research and development, regulatory affairs, and clinical trial operations. He was most recently the Vice President of Phase IV Clinical Operations at Pharmanet where he was also a member of the Executive Committee. His many accomplishments include a history of numerous successful NDA submissions and approvals; managing, directing and building corporate development efforts to the point of merger and acquisition; and the co-developer of a patented novel pharmaceutical dosage form. He has also served on the Board of Directors at Somerset Pharmaceuticals. He began his career at Sandoz Pharmaceuticals in project management and regulatory affairs. Mr. LaBella received his undergraduate degree in pharmacy from the University of Connecticut and his graduate degree from the Arnold and Marie Schwartz College of Pharmacy and Health Sciences. | 